Hormone Therapy - malecare.org

Long-Term Effects of Intermittent Androgen Suppression on Testosterone Recovery and Bone Mineral Density: Results of a 33-Month Observational Study

A phase II trial was just completed at the University of Western Australia to investigate changes in bone mineral density (BMD) and osteoporosis in men on intermittent androgen-suppression therapy (IAST) over a period of three years. This trial, conducted at the Faculty of Medicine, University of Western Australia, Crawley, Department of Radiation Oncology, Sir Charles [...]

By Malecare|2009-04-20T07:00:17-04:00April 20th, 2009|Advanced Prostate Cancer, Bone Mineral Density, Drugs & Treatments, Hormone Therapy, Research, Uncategorized, Understanding APC|0 Comments

Sexual Behavior At Work Still A Problem

A new paper published in the Journal of Applied Psychology and co-authored by researchers from the University of Toronto’s Rotman School of Management and the University of British Columbia's Sauder School of Management concluded that sexual behavior at work creates a problem in the work place, especially morale. The study looks at sexual behavior in [...]

By Malecare|2009-04-08T10:11:25-04:00April 8th, 2009|Advanced Prostate Cancer, Hormone Therapy, Uncategorized|0 Comments

Denosumab Increased Bone Mineral Density in Men With Nonmetastatic Prostate Cancer

Presented at EAU on March 23, 2009 The drug Denosumab has shown itself both easy to tolerate by patients as well highly able to increases bone mineral density (BMD) when compared with placebo in men with nonmetastatic prostate cancer receiving androgen deprivation therapy (ADT). The results of this multi-centre, randomized, double-blind, placebo-controlled, phase 3 study [...]

By Malecare|2009-04-01T09:40:05-04:00April 1st, 2009|Advanced Prostate Cancer, Bone Mineral Density, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, Uncategorized, Understanding APC|0 Comments

Continious ADT vs Intermittent – There is a Winner From This Trial

One of the unsettled debates in our advanced prostate cancer world surrounds the issue of continuous vs. intermittent hormone therapy (IHT). Traditionally, hormone therapy was continuous, or once you started you never stopped the treatment. As many of us know, hormone therapy is notorious for damaging the quality of life. Hot flashes, loss of libido, [...]

By Malecare|2017-10-19T10:55:48-04:00March 31st, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, How We Live, Uncategorized, Understanding APC|0 Comments

Using Gabapentin to Control Hot Flashes with ADT

A small phase III, randomized, double blind, placebo controlled trial of Gabapentin which looked at the Management of hot flashes in men on a hormone blockade (ADT) was recently completed and published in the March 2009 journal of the Ann of Oncology. One of the most common and bothersome side effects of a hormone blockade [...]

By Malecare|2017-10-19T10:55:58-04:00March 17th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, How We Live, Uncategorized, Understanding APC|0 Comments